Pheasant breeding density refers to the number of pheasants contained per unit area. Excessive density may hinder pheasant feeding, drinking, and exercise. The weak pheasants are more affected, the density is too low, the utilization of equipment is low, and the feeding cost is increased. In general, the bulk density should be smaller and the bulk density can be larger. These days, the age may be less dense, and the days of age may be greater. It can be dense in winter and sparse in summer.
The pheasant stocking density directly affects the growth and development of the chicks, the uniformity of the flock, the average weight, the brood survival rate and the health status. The stocking density is too large, the above indicators become worse, the stocking density is too small, and the utilization rate of the houses is low.
Pheasant within 10 days of age: raise 60-80 pheasants per square meter within 20 days of age: raise 30-40 pheasants per square meter within 30 days of age: raise 25-30 per square meter Note: different ways of de-warming, The density is slightly different. In general, the density of cages can be slightly higher, and the density of ground flats is slightly lower. After the temperature is defrosted, it is adjusted according to the growth of age and the way of feeding and the price segment.
Content sources Albert pheasants
Respiratory disease is a common disease, frequently-occurring disease, the main lesion in the trachea, bronchi, lung and chest, lesions are more cough, chest pain, respiratory effects, severe breathing difficulties, hypoxia, and even respiratory failure and death. Due to air pollution, smoking and other factors, The chronic obstructive pulmonary disease is increasing including chronic bronchitis, emphysema, pulmonary heart disease, bronchial asthma, lung cancer, pulmonary diffuse interstitial fibrosis, and pulmonary infection the morbidity and mortality of the disease at home and abroad . Therefore, anti-respiratory disease drugs are also more and more attention paid by researchers. Respiratory disease have the symptoms of cough, sputum, hemoptysis, chest pain, shortness of breath and other symptoms of lack of specificity, often clinicians mistaken by people for colds, bronchitis, and severe pneumonia, tuberculosis or lung cancer and other diseases delayed diagnosis; Respiratory tract infection, to be developed to emphysema, pulmonary heart disease, respiratory failure was taken seriously, but it was too late, its pathology and physiological function has been difficult to reverse. As with other systemic diseases, careful and detailed medical history and physical examination are the basis for the diagnosis of respiratory diseases, and should be combined with routine laboratory tests and other special findings to conduct a comprehensive and comprehensive analysis. Currently the most clinical application of anti-respiratory disease drugs have the following four categories: 1. Antihistamines 2. Cough medicine 3. Bronchodilator 4. Expectorant 5. Anti-asthma drugs.
Anti-asthma Drugs, Antitussives, Expectorants, β adrenergic receptor agonists, M Cholinergic Blockers, Phosphodiesterase Inhibitors, Anti-Respiratory Drugs,Respiratory System Diseases Treatment
Taizhou Volsen Chemical Co., Ltd. , https://www.volsenchem.com